Biosimilars
-
Faster Paths To Biosimilar Equivalence: Turning Guidance Into An Advantage
9/1/2026
Evolving biosimilar guidance creates opportunities to reduce comparative clinical requirements through strong analytical evidence, risk-based justification, structure-function knowledge, and more.